Development of a Neutralization Assay for Influenza Virus Using an Endpoint Assessment Based on Quantitative Reverse-Transcription PCR

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Teferedegne, Belete ^a   Lewis, Andrew M ^a   Peden, Keith ^a   Murata, Haruhiko ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A; INTERMETHOD COMPARISON; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY ANALYSIS; SEROLOGY; SIGNAL DETECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION;

EID: 84874251074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056023     Document Type: Article

References (35)

1. Katz JM, Hancock K, Xu X, (2011) Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 9: 669-683.
2. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
3. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, et al. (2010) Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 10: 18.
4. Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, et al. (2010) Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 28: 1156-1167.
5. Lin YP, Gregory V, Collins P, Kloess J, Wharton S, et al. (2010) Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol 84: 6769-6781.
6. World Health Organization website (Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza). Available: http://www.who.int/influenza/gisrs_laboratory/manual_diagnosis_surveillance_influenza/en/index.html. Accessed 2013 Jan 25.
7. Klimov A, Balish A, Veguilla V, Sun H, Schiffer J, et al. (2012) Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol 865: 25-51.
8. Grund S, Adams O, Wahlisch S, Schweiger B, (2011) Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J Virol Methods 171: 369-373.
9. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, et al. (2011) Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 49: 2210-2215.
10. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37: 937-943.
11. Stephenson I, Das RG, Wood JM, Katz JM, (2007) Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 25: 4056-4063.
12. Stephenson I, Heath A, Major D, Newman RW, Hoschler K, et al. (2009) Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 15: 1252-1259.
13. Wood JM, Major D, Heath A, Newman RW, Hoschler K, et al. (2012) Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 30: 210-217.
14. Saito T, Munakata Y, Fu Y, Fujii H, Kodera T, et al. (2003) Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction. J Virol Methods 107: 81-87.
15. van Santen VL, Kaltenboeck B, Joiner KS, Macklin KS, Norton RA, (2004) Real-time quantitative PCR-based serum neutralization test for detection and titration of neutralizing antibodies to chicken anemia virus. J Virol Methods 115: 123-135.
16. Wong S, Brown KE, (2006) Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35: 407-413.
17. Yuan L, Zhang X, Chang M, Jia C, Hemmingsen SM, et al. (2007) A new fluorescent quantitative PCR-based in vitro neutralization assay for white spot syndrome virus. J Virol Methods 146: 96-103.
18. Kramski M, Drozd A, Lichtfuss GF, Dabrowski PW, Ellerbrok H, (2011) Rapid detection of anti-Vaccinia virus neutralizing antibodies. Virol J 8: 139.
19. Murata H, Teferedegne B, Lewis AM Jr, Peden K, (2009) A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applications. J Virol Methods 162: 236-244.
20. Wang W, Anderson CM, De Feo CJ, Zhuang M, Yang H, et al. (2011) Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog 7: e1002081.
21. Reed LJ, Muench H, (1938) A simple method estimating fifty per cent endpoints. Am J Hyg 27: 493-497.
22. Ward CL, Dempsey MH, Ring CJ, Kempson RE, Zhang L, et al. (2004) Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 29: 179-188.
23. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
24. Andrewes CH, Elford WJ, (1933) Observations on anti-phage sera. I: "The percentage law". Br J Exp Pathol 14: 367-376.
25. Klasse PJ, Sattentau QJ, (2002) Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol 83: 2091-2108.
26. Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss BJ, et al. (2006) A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65.
27. Alberini I, Del Tordello E, Fasolo A, Temperton NJ, Galli G, et al. (2009) Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses. Vaccine 27: 5998-6003.
28. Kong WP, Hood C, Yang ZY, Wei CJ, Xu L, et al. (2006) Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci U S A 103: 15987-15991.
29. Nefkens I, Garcia JM, Ling CS, Lagarde N, Nicholls J, et al. (2007) Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 39: 27-33.
30. Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, et al. (2007) A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respi Viruses 1: 105-112.
31. Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, et al. (2008) Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods 153: 111-119.
32. Tsai C, Caillet C, Hu H, Zhou F, Ding H, et al. (2009) Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine 27: 6777-6790.
33. Seitz C, Frensing T, Hoper D, Kochs G, Reichl U, (2010) High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol 91: 1754-1763.
34. Seitz C, Isken B, Heynisch B, Rettkowski M, Frensing T, et al. (2012) Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Appl Microbiol Biotechnol 93: 601-611.
35. Hale BG, Randall RE, Ortin J, Jackson D, (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-2376.